PRL and cancer: Since it is the indirect results of interacting transcription factors, the ranges get larger and are involved with the FoxO and JAK-STAT signaling pathway, immunity (e.g., Th17 cell differentiation), viral infection (e.g., measles and viral hepatitis), hormones (e.g., prolactin), metabolism, and cancer.